SIRPA and colorectal carcinoma: Blockade of the well-known CD47-SIRPα “don’t eat me signal” using monoclonal antibodies increases macrophage-mediated phagocytosis and elimination of various solid tumors (34–36), however, this therapeutic schedule may be not suit to hypoxic CRC because the expression of CD47 showed uncorrelated trend with hypoxia.